Last reviewed · How we verify

NCT05782738: T-REX

Reverse T-stenting and Minimal Protrusion With External Minicrush for Treatment of Complex Coronary Bifurcation

Not yet recruiting NA Last updated 19 April 2023
What this trial tests

NA trial testing Percutaneous Coronary Intervention in Coronary Artery Disease in 361 participants. Not yet recruiting.

Timeline
1 June 2023
Primary endpoint
1 June 2026
1 June 2029

Quick facts

Lead sponsorSan Luigi Gonzaga Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment361
Start date1 June 2023
Primary completion1 June 2026
Estimated completion1 June 2029
Sites5 locations across Italy

Drugs / interventions tested

Conditions studied

Sponsor

San Luigi Gonzaga Hospital

Who can join

18 and older, any sex, with Coronary Artery Disease or Coronary Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Reverse T-stenting And Minimal Protrusion (Reverse TAP) is an up-front 2-stent technique that treats complex coronary bifurcation. Compared to crush techniques, it does not require crushing of the side branch stent but only minimal protrusion of the side branch stent before main vessel stenting. Nowadays, no studies compare the Reverse-TAP and the External Minicrush in treating complex coronary bifurcation, so eventually, procedural, clinical and safety differences remain unknown.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Percutaneous Coronary Intervention

Trials testing the same drug.

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other San Luigi Gonzaga Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05782738.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing